Centre for Translational Biology (CTB)

The Centre for Translational Biology (CTB) is one of the three RI-MUHC research centres, which unite RI-MUHC researchers from eight interdisciplinary research programs.

CTB researchers are engaged in fundamental biomedical research, using a wide range of models and interdisciplinary approaches to understand the many factors contributing to human health. The CTB includes more than 150 RI-MUHC scientists and their teams, located at the Glen site and Montreal General Hospital (MGH) site of the McGill University Health Centre (MUHC).

The CTB houses nine core facilities or technology platforms, whose mission is to provide internal and external users access to state-of-the-art technologies and instrumentation, top-level scientific expertise, and the training necessary to promote cutting-edge research.

CTB Researchers

Profiles of CTB researchers may be accessed via their affiliated Research Program:

CTB News and Events

Newspaper Icon

We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

Calendar Icon

The Centre for Translational Biology (CTB) organizes and supports numerous speakers, seminars, and symposia throughout the year.

CTB Technology Platforms

The CTB houses nine core facilities or technology platforms, whose mission is to provide internal and external users access to state-of-the-art technologies and instrumentation, top-level scientific expertise, and the training necessary to promote cutting-edge research.

Biobank Platform logo

The Biobank Platform fosters ethical studies of human tissues by providing expert regulatory support, sample collection and secure storage.

Bioinformatics Platform logo

The Bioinformatics Platform accelerates genomics research and its applications in clinical practice, combining expertise in bioinformatics, human genetics, next-generation sequencing and molecular diagnosis.

Containment Level 3 (CL3) Platform logo

The Containment Level 3 (CL3) Platform is a state-of-the-art biosafety facility combining the latest instrumentation for cell sorting and DNA sequencing for research on live pathogenic bacteria and viruses.

Drug Discovery Platform logo

The Drug Discovery Platform provides analytical support to help clients identify and validate new medications with nuclear magnetic resonance (NMR) spectroscopy, MALDI mass imaging, and mass spectroscopy (MS).

Histopathology Platform logo

The Histopathology Platform features high-throughput, multiplex detection procedures to visualize complex biological structures and molecular components within soft tissues and bones.

Immunophenotyping Platform logo

The Immunophenotyping Platform is equipped with high-speed, multicolour flow cytometers and cell sorters that count and sort cells for detailed research and precision phenotyping.

Molecular Imaging Platform logo

The Molecular Imaging Platform offers superb technologies for high-resolution and super-resolution microscopy, providing still images and real-time movies of events as they occur within living tissues and organisms.

Proteomics Platform logo

The Proteomics Platform maps large-scale proteomics data onto pathways and functional interaction networks, and provides customized services for measuring levels of small molecules such as peptides, steroids, neurotransmitters, and cannabis metabolites.

Small Animal Imaging Labs (SAIL) Platform logo

The Small Animal Imaging Labs (SAIL) Platform is a unique and comprehensive technology suite for non-invasive imaging (MRI, PET, CT, SPECT) in pre-clinical animal models.

RI-MUHC members also benefit from the Brain Imaging Centre (BIC) at the Montreal Neurological Institute (MNI) which facilitates the development of new techniques for imaging of humans and animals. The BIC’s facilities include some of the most advanced magnetic resonance (MR), positron emission tomography (PET), and magnetoencephalography (MEG) imaging devices available.

Additionally, the RI-MUHC supports animal facilities equipped with state-of-the art imaging facilities at the Glen, MGH and MNI.

At the MNI, the Healthy Brains for Healthy Lives program (HBHL) supports the operations and expansion of core facilities and technology development platforms.

CTB Leadership

Don van Meyel, PhD
Don van Meyel, PhD

Director, Centre for Translational Biology (CTB)

Contact the CTB Technology Platforms

We welcome inquiries from researchers seeking access to the technologies, instrumentation and expertise available in the CTB Technology Platforms.

Patrice Vaillancourt
Patrice Vaillancourt

Manager, Operations and Platforms

Useful links

Explore research at the RI-MUHC